In a sweeping legal resolution, Attorney General Brian L. Schwalb has wrangled a hefty $7.4 billion settlement from Purdue Pharma and the Sackler family, with a direct payout of over $21 million earmarked for the District over the next couple of years. As reported by the Office of the Attorney General, this move marks a significant step in addressing the devastating opioid crisis that has gripped the nation for decades. All 55 attorneys general representing states and US territories have agreed to the terms, ready to put the funds to work in addiction treatment, prevention, and recovery efforts.
Relinquishing their control, the Sackler family is bowing out of the opioid business in the United States, as part of the settlement. This comes after serious allegations were brought to light regarding Purdue's role in deceptively marketing opioids, perceived by the public as safe due to their aggressive advertising tactics. Having promoted the long-term and high-dose usage of these products, Purdue stands accused of significantly contributing to the drug crisis. The settlement signals the end of an era for Purdue and the Sacklers in opioids, as stated by the Attorney General in a release from his office.
Local communities are poised to benefit from the funds, which are slated to be distributed over the next 15 years. This allocation reflects a targeted approach to tackle the widespread issue of opioid addiction, investing in the infrastructure needed to support individuals struggling with substance abuse. Clearing the haze of this long-standing public health emergency, the focus now shifts to healing and rebuilding the lives and communities ravaged by addiction.
The Sacklers have agreed to a settlement in which they will exit the opioid market. The agreement marks the largest financial settlement to date related to the opioid crisis, as reported by the Office of the Attorney General.
